Industry

One of the most significant trends shaping the market today is the rise of mergers and acquisitions (M&A). Large companies in the pharmaceutical industry have been acquiring smaller biotech firms. In result, expanding their pipelines and investing in groundbreaking therapies. How Mergers and Acquisitions Drive Innovation Companies like Novartis are demonstrating a strong interest in […]

The pharmaceutical industry is undergoing a transformative shift, with artificial intelligence (AI) and big data analytics playing a crucial role in accelerating medication discovery and development. Companies are leveraging these cutting-edge technologies to streamline research, improve efficiency, and enhance patient outcomes. As the demand for faster and more cost-effective medication development grows, AI-driven approaches are

Pharmapack 2025, one of the most anticipated events in the pharmaceutical and healthcare industries, is set to take place in Paris, France. Scheduled for this month, this global gathering will bring together key players from pharmaceutical packaging, medication delivery, medical devices, and machinery sectors. The event promises to spotlight cutting-edge innovations and foster meaningful collaborations

When you think about the NFL Draft, images of scouts, strategy, and high-stakes decisions come to mind. Big Pharma, on the other hand, conjures up thoughts of clinical trials, research breakthroughs, and regulatory hurdles. At first glance, these two industries might seem worlds apart. However, for investors, the parallels between the NFL Draft and Big

The high cost of insulin has been a significant concern in the United States for years. Millions of people depend on this life-saving medication, yet its price continues to rise, putting a heavy financial burden on patients with diabetes. Recently, the Federal Trade Commission (FTC) took action, filing a lawsuit against prescription middlemen, accusing them

Recent data from a new ASHP (American Society of Health-System Pharmacists) report reveals an intriguing trend in prescription medication spending across the United States. While the overall national expenditure experienced a significant surge, increasing by 13.5% from 2022 to 2023 and totaling a staggering $722.5 billion, this growth was not mirrored in hospital pharmacy spending.

In a significant legal development, the 5th Circuit Court partially affirmed a ruling that deemed the Preventive Services Task Force unconstitutional. This task force is responsible for determining the coverage of certain preventive services under the Affordable Care Act (ACA). Additionally, the appellate court upheld the grant of injunctive relief for the plaintiffs in the

April 2nd marks a significant step in the ongoing battle against medication shortages as the U.S. Department of Health and Human Services (HHS) releases a comprehensive white paper addressing the issue head-on. Medication shortages have plagued the nation’s healthcare system for decades, primarily due to market failures and misaligned incentives. With the release of this